Microsatellite instability evaluation of patients with solid tumour: routine practice insight from a large series of Italian referral centre
暂无分享,去创建一个
M. Fassan | P. Graziano | G. Troncone | C. Bellevicine | U. Malapelle | P. Parente | P. Pallante | E. Vigliar | P. Pisapia | A. Iaccarino | F. Pepe | G. Russo | Mariantonia Nacchio | Lucia Palumbo | Claudio Bellevicine
[1] M. Fassan,et al. Evaluation of Micro Satellite Instability and Mismatch Repair Status in Different Solid Tumors: A Multicenter Analysis in a Real World Setting , 2021, Cells.
[2] J. Toh,et al. A Simple, Accurate and Cost-Effective Capillary Electrophoresis Test with Computational Methods to Aid in Universal Microsatellite Instability Testing , 2021, Cells.
[3] P. Gibbs,et al. Pembrolizumab in Microsatellite-Instability-High Advanced Colorectal Cancer. , 2020, The New England journal of medicine.
[4] M. Fassan,et al. Impact of Pre-Analytical Factors on MSI Test Accuracy in Mucinous Colorectal Adenocarcinoma: A Multi-Assay Concordance Study , 2020, Cells.
[5] A. Scarpa,et al. ESMO recommendations on microsatellite instability testing for immunotherapy in cancer, and its relationship with PD-1/PD-L1 expression and tumour mutational burden: a systematic review-based approach. , 2019, Annals of oncology : official journal of the European Society for Medical Oncology.
[6] F. Staroz,et al. Microsatellite instability diagnosis using the fully automated Idylla platform: feasibility study of an in-house rapid molecular testing ancillary to immunohistochemistry in pathology laboratories , 2019, Journal of Clinical Pathology.
[7] M. Fassan,et al. Microfluidic chip technology applied to fine‐needle aspiration cytology samples for IGH clonality assessment , 2019, Diagnostic cytopathology.
[8] K. Stefánsson,et al. Clinical characteristics of patients with colorectal cancer with double somatic mismatch repair mutations compared with Lynch syndrome , 2019, Journal of Medical Genetics.
[9] P. Keegan,et al. FDA Approval Summary: Pembrolizumab for the Treatment of Microsatellite Instability-High Solid Tumors , 2019, Clinical Cancer Research.
[10] N. Lee,et al. The therapeutic significance of mutational signatures from DNA repair deficiency in cancer , 2018, Nature Communications.
[11] X. Qian,et al. Comparison of microsatellite status detection methods in colorectal carcinoma. , 2018, International journal of clinical and experimental pathology.
[12] G. Troncone,et al. Microsatellite instability evaluation by automated microfluidic electrophoresis: an update , 2016, Journal of Clinical Pathology.
[13] G. Troncone,et al. EGFR mutant allelic-specific imbalance assessment in routine samples of non-small cell lung cancer , 2015, Journal of Clinical Pathology.
[14] R. Broaddus,et al. Role of microsatellite instability-low as a diagnostic biomarker of Lynch syndrome in colorectal cancer. , 2014, Cancer genetics.
[15] G. Troncone,et al. EGFR mutation detection by microfluidic technology: a validation study , 2013, Journal of Clinical Pathology.
[16] Helen M. Moore,et al. Effects of preanalytical variables on the detection of proteins by immunohistochemistry in formalin-fixed, paraffin-embedded tissue. , 2011, Archives of pathology & laboratory medicine.
[17] J. Shia. Immunohistochemistry versus microsatellite instability testing for screening colorectal cancer patients at risk for hereditary nonpolyposis colorectal cancer syndrome. Part I. The utility of immunohistochemistry. , 2008, The Journal of molecular diagnostics : JMD.
[18] P. Modrich,et al. DNA mismatch repair: functions and mechanisms. , 2006, Chemical reviews.
[19] R. Houlston,et al. Systematic review of microsatellite instability and colorectal cancer prognosis. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[20] Sudhir Srivastava,et al. Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. , 2004, Journal of the National Cancer Institute.